Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Glioblastoma × Neoadjuvant Therapy × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Lung Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Adenocarcinoma Of Esophagus 4 Sarcoma 3 Rectal Neoplasms 3 Colorectal Neoplasms 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Multiple Myeloma 2 Kidney Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Renal Cell 2 Carcinoma, Intraductal, Noninfiltrating 2 Vomiting 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Teratoma 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Prostate Adenocarcinoma 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1

Interventions

Temozolomide 104 Bevacizumab 64 Radiotherapy 45 Radiation 21 Erlotinib Hydrochloride 12 pembrolizumab 10 Magnetic Resonance Spectroscopy 10 Lomustine 10 Vorinostat 9 Irinotecan 9 Nivolumab 8 Surgical Procedures, Operative 7 Radiotherapy, Intensity-Modulated 7 Immunoglobulin G 7 Disulfides 7 Sorafenib 6 Radiotherapy, Conformal 6 Radiosurgery 6 Drug Therapy 6 Carmustine 6 antineoplaston AS 2-1 5 antineoplaston A10 5 Granulocyte-Macrophage Colony-Stimulating Factor 5 Everolimus 5 veledimex 4 selinexor 4 sargramostim 4 cediranib 4 Dasatinib 4 Cilengitide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡